Figures & data
Figure 1 Subject recruitment procedure in current study.
![Figure 1 Subject recruitment procedure in current study.](/cms/asset/caac39a0-7a22-4d3c-9c94-3f17d6658ef0/dndt_a_71997_f0001_b.jpg)
Table 1 Demographic and clinical characteristics of subjects included in current study
Figure 2 (A) 5-methylcytosine (5-mc) and (B) 5-hydroxymethylcytosine (5-hmc) levels in patients with severe major depressive disorder (MDD), remitted MDD, and healthy controls, divided by sex (n=30 in males and n=44 in females).
![Figure 2 (A) 5-methylcytosine (5-mc) and (B) 5-hydroxymethylcytosine (5-hmc) levels in patients with severe major depressive disorder (MDD), remitted MDD, and healthy controls, divided by sex (n=30 in males and n=44 in females).](/cms/asset/1dd61664-d538-4171-ad17-fc98e1a0072b/dndt_a_71997_f0002_b.jpg)
Figure 3 (A) 5-methylcytosine (5-mc) and (B) 5-hydroxymethylcytosine (5-hmc) levels in patients with severe major depressive disorder (MDD), remitted MDD, and healthy controls, in different age groups (n=14 for younger group, n=29 for middle-age group, and n=31 for older age group).
![Figure 3 (A) 5-methylcytosine (5-mc) and (B) 5-hydroxymethylcytosine (5-hmc) levels in patients with severe major depressive disorder (MDD), remitted MDD, and healthy controls, in different age groups (n=14 for younger group, n=29 for middle-age group, and n=31 for older age group).](/cms/asset/81d50ee4-6ed7-4011-a82c-275db48c756e/dndt_a_71997_f0003_b.jpg)
Figure 4 Scatterplots of the correlation between (A) 5-methylcytosine (5-mc) levels, and (B) 5-hydroxymethylcytosine (5-hmc) levels and the severity of depressive symptoms shown as HAM-D.
Abbreviation: HAM-D, Hamilton Depression Rating Scale.
![Figure 4 Scatterplots of the correlation between (A) 5-methylcytosine (5-mc) levels, and (B) 5-hydroxymethylcytosine (5-hmc) levels and the severity of depressive symptoms shown as HAM-D.](/cms/asset/ac2e9d60-ea8d-4abd-81f6-d45c7a54816b/dndt_a_71997_f0004_b.jpg)